Niels‐Ulrik Korbinian Hartmann

Long COVID‐19: Objectifying most self‐reported neurological symptoms

Julia Bungenberg, Karen Humkamp, Christian Hohenfeld et al. · Annals of Clinical and Translational Neurology · 2022 · 132 citations · Full text

Medicine, Infectious Diseases, Neurology +17

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study

Matthias Rau, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann et al. · Cardiovascular Diabetology · 2021 · 70 citations · Full text

Medicine, Cardiology, Pharmacology +17

Effects of empagliflozin on erythropoiesis in patients with type 2 diabetes: Data from a randomized, placebo‐controlled study

Kirsten Thiele, Matthias Rau, Niels‐Ulrik Korbinian Hartmann et al. · Diabetes Obesity and Metabolism · 2021 · 63 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Empagliflozin Reduces Markers of Acute Kidney Injury in Patients with Acute Decompensated Heart Failure

Kirsten Thiele, Matthias Rau, Niels‐Ulrik Korbinian Hartmann et al. · ESC Heart Failure · 2022 · 41 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Six Months Follow-Up of Patients with Invasive Mechanical Ventilation Due to COVID-19 Related ARDS

Ayham Daher, Christian Cornélissen, Niels‐Ulrik Korbinian Hartmann et al. · International Journal of Environmental Research and Public Health · 2021 · 38 citations · Full text

Medicine, Internal Medicine, Pulmonary Function Testing +14